March 12, 2020 / 11:46 AM / in 20 days

BRIEF-Galmed Pharmaceuticals Posts Q4 Loss Per Share Of $0.39

March 12 (Reuters) - Galmed Pharmaceuticals Ltd:

* GALMED PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND YEAR END 2019 FINANCIAL RESULTS

* QTRLY LOSS PER SHARE OF $0.39

* GALMED PHARMACEUTICALS - CASH & CASH EQUIVALENTS, RESTRICTED CASH, SHORT-TERM DEPOSITS,MARKETABLE DEBT SECURITIES TOTALED $75.6 MILLION AS OF DEC 31, 2019

* Q4 EARNINGS PER SHARE VIEW $-0.34 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below